Liposomal amphotericin B as a treatment for human leishmaniasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liposomal amphotericin B as a treatment for human leishmaniasis

Published:2012-11-20 Issue:4 Volume:17 Page:493-510
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Balasegaram Manica,Ritmeijer Koert,Lima Maria Angeles,Burza Sakib,Ortiz Genovese Gemma,Milani Barbara,Gaspani Sara,Potet Julien,Chappuis François

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728214.2012.748036

Reference64 articles.

1. Leishmaniasis Worldwide and Global Estimates of Its Incidence

2. Drug resistance in Indian visceral leishmaniasis

3. Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial

4. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

5. Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization and Evaluation of Microwave-Synthesized Nanostructured Lipid Carriers for Enhanced Amphotericin B Efficacy Against Leishmania donovani: A Novel Therapeutic Paradigm;BioNanoScience;2024-08-01

2. N‐Pyrazolyl‐ and N‐Triazolylamines and ‐Ureas as Antileishmanial and Antitrypanosomal Drugs;ChemMedChem;2024-06-19

3. The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis;Pharmaceutics;2024-02-04

4. Anti- Leishmania compounds can be screened using Leishmania spp. expressing red fluorescence ( tdTomato );Antimicrobial Agents and Chemotherapy;2024-01-10

5. The Concurrence of Visceral Leishmaniasis and Acquired Immunodeficiency Syndrome: Current Impact and Challenges;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3